Abivax (ABVX) Other Working Capital Changes (2024 - 2026)

Abivax's Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$14.4 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes changed N/A year-over-year to -$14.4 million in Q1 2026; TTM through Mar 2026 was -$13.8 million, a 9441.9% decrease from a year earlier, with the FY2025 full-year figure at $52.0 million, changed N/A from the prior year.
• Other Working Capital Changes eased to -$14.4 million in Q1 2026 per ABVX's latest filing, from $1.5 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $1.5 million in Q4 2025 and bottomed at -$14.4 million in Q1 2026.
• The 3-year median for Other Working Capital Changes is -$149826.3 (2024), against an average of -$1.7 million.
• Biggest YoY gain for Other Working Capital Changes was 251.93% in 2025; the steepest drop was 259.27% in 2025.
• Year by year, Other Working Capital Changes stood at $430643.9 in 2024, then jumped by 251.93% to $1.5 million in 2025, then sank by 1052.84% to -$14.4 million in 2026.
• Per Business Quant, the three latest ABVX Other Working Capital Changes figures stand at -$14.4 million (Q1 2026), $1.5 million (Q4 2025), and -$378773.8 (Q3 2025).